YAC transgenics and the study of genetics and human disease

Bruce Lamb, John D. Gearhart

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Advances in yeast artificial chromosome (YAC) technologies over the past decade have enabled the precise identification and manipulation of large genomic regions (>100 kb) of DNA. Introduction of YACs into the mouse germline has now been accomplished through transfection of mouse embryonic stem cells as well as through pronuclear microinjection, allowing the efficient transfer of defined genomic loci into mice. YAC transgenics will have a profound impact on the development of transgenic mice as bioreactors and as models of human disease, and on the functional analysis of higher order genomic structure.

Original languageEnglish (US)
Pages (from-to)342-348
Number of pages7
JournalCurrent Opinion in Genetics and Development
Volume5
Issue number3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Yeast Artificial Chromosomes
Inborn Genetic Diseases
Microinjections
Bioreactors
Transgenic Mice
Transfection
Technology
DNA
Mouse Embryonic Stem Cells

ASJC Scopus subject areas

  • Developmental Biology
  • Genetics

Cite this

YAC transgenics and the study of genetics and human disease. / Lamb, Bruce; Gearhart, John D.

In: Current Opinion in Genetics and Development, Vol. 5, No. 3, 1995, p. 342-348.

Research output: Contribution to journalArticle

@article{b5c4fdaa25e74bf5967e874116c4eb8c,
title = "YAC transgenics and the study of genetics and human disease",
abstract = "Advances in yeast artificial chromosome (YAC) technologies over the past decade have enabled the precise identification and manipulation of large genomic regions (>100 kb) of DNA. Introduction of YACs into the mouse germline has now been accomplished through transfection of mouse embryonic stem cells as well as through pronuclear microinjection, allowing the efficient transfer of defined genomic loci into mice. YAC transgenics will have a profound impact on the development of transgenic mice as bioreactors and as models of human disease, and on the functional analysis of higher order genomic structure.",
author = "Bruce Lamb and Gearhart, {John D.}",
year = "1995",
doi = "10.1016/0959-437X(95)80049-2",
language = "English (US)",
volume = "5",
pages = "342--348",
journal = "Current Opinion in Genetics and Development",
issn = "0959-437X",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - YAC transgenics and the study of genetics and human disease

AU - Lamb, Bruce

AU - Gearhart, John D.

PY - 1995

Y1 - 1995

N2 - Advances in yeast artificial chromosome (YAC) technologies over the past decade have enabled the precise identification and manipulation of large genomic regions (>100 kb) of DNA. Introduction of YACs into the mouse germline has now been accomplished through transfection of mouse embryonic stem cells as well as through pronuclear microinjection, allowing the efficient transfer of defined genomic loci into mice. YAC transgenics will have a profound impact on the development of transgenic mice as bioreactors and as models of human disease, and on the functional analysis of higher order genomic structure.

AB - Advances in yeast artificial chromosome (YAC) technologies over the past decade have enabled the precise identification and manipulation of large genomic regions (>100 kb) of DNA. Introduction of YACs into the mouse germline has now been accomplished through transfection of mouse embryonic stem cells as well as through pronuclear microinjection, allowing the efficient transfer of defined genomic loci into mice. YAC transgenics will have a profound impact on the development of transgenic mice as bioreactors and as models of human disease, and on the functional analysis of higher order genomic structure.

UR - http://www.scopus.com/inward/record.url?scp=0029063916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029063916&partnerID=8YFLogxK

U2 - 10.1016/0959-437X(95)80049-2

DO - 10.1016/0959-437X(95)80049-2

M3 - Article

C2 - 7549429

AN - SCOPUS:0029063916

VL - 5

SP - 342

EP - 348

JO - Current Opinion in Genetics and Development

JF - Current Opinion in Genetics and Development

SN - 0959-437X

IS - 3

ER -